Currently, eleven COVID-19 vaccines have been granted for emergency use by the WHO, with formulations mostly encoding and targeting the surface glycoprotein (S protein) of the SARS-CoV-2, including the use of inactivated whole viruses [10–12]. The gene discussed is PROS1; the disease is COVID-19.